101 related articles for article (PubMed ID: 31543974)
1. FOXN3 hyperglycemic risk allele and insulin sensitivity in humans.
Erickson ML; Karanth S; Ravussin E; Schlegel A
BMJ Open Diabetes Res Care; 2019; 7(1):e000688. PubMed ID: 31543974
[TBL] [Abstract][Full Text] [Related]
2. A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose.
Karanth S; Adams JD; Serrano MLA; Quittner-Strom EB; Simcox J; Villanueva CJ; Ozcan L; Holland WL; Yost HJ; Vella A; Schlegel A
Cell Rep; 2018 Jul; 24(2):312-319. PubMed ID: 29996093
[TBL] [Abstract][Full Text] [Related]
3. FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection.
Karanth S; Chaurasia B; Bowman FM; Tippetts TS; Holland WL; Summers SA; Schlegel A
Physiol Rep; 2019 Sep; 7(18):e14238. PubMed ID: 31552709
[TBL] [Abstract][Full Text] [Related]
4. The FOXO3A rs2802292 G-allele associates with improved peripheral and hepatic insulin sensitivity and increased skeletal muscle-FOXO3A mRNA expression in twins.
Banasik K; Ribel-Madsen R; Gjesing AP; Wegner L; Andersson A; Poulsen P; Borglykke A; Witte DR; Pedersen O; Hansen T; Vaag A
J Clin Endocrinol Metab; 2011 Jan; 96(1):E119-24. PubMed ID: 20881262
[TBL] [Abstract][Full Text] [Related]
5. FOXN3 Regulates Hepatic Glucose Utilization.
Karanth S; Zinkhan EK; Hill JT; Yost HJ; Schlegel A
Cell Rep; 2016 Jun; 15(12):2745-55. PubMed ID: 27292639
[TBL] [Abstract][Full Text] [Related]
6. The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemia.
Heni M; Ketterer C; Hart LM; Ranta F; van Haeften TW; Eekhoff EM; Dekker JM; Boomsma DI; Nijpels G; Kramer MH; Diamant M; Simonis-Bik AM; Heine RJ; de Geus EJ; Schäfer SA; Machicao F; Ullrich S; Thamer C; Stefan N; Staiger H; Häring HU; Fritsche A
J Clin Endocrinol Metab; 2010 Dec; 95(12):E479-84. PubMed ID: 20826583
[TBL] [Abstract][Full Text] [Related]
7. Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes.
Müssig K; Staiger H; Machicao F; Stancáková A; Kuusisto J; Laakso M; Thamer C; Machann J; Schick F; Claussen CD; Stefan N; Fritsche A; Häring HU
J Clin Endocrinol Metab; 2009 Apr; 94(4):1353-60. PubMed ID: 19141580
[TBL] [Abstract][Full Text] [Related]
8. C825T polymorphism of the G protein beta3 subunit is associated with obesity but not with insulin sensitivity.
Stefan N; Stumvoll M; Machicao F; Koch M; Häring HU; Fritsche A
Obes Res; 2004 Apr; 12(4):679-83. PubMed ID: 15090636
[TBL] [Abstract][Full Text] [Related]
9. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
[TBL] [Abstract][Full Text] [Related]
10. Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double-blind crossover trial.
Lee WG; Murphy R; McCall JL; Gane EJ; Soop M; Tura A; Plank LD
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27667324
[TBL] [Abstract][Full Text] [Related]
11. The rs7903146 Variant in the
Cropano C; Santoro N; Groop L; Dalla Man C; Cobelli C; Galderisi A; Kursawe R; Pierpont B; Goffredo M; Caprio S
Diabetes Care; 2017 Aug; 40(8):1082-1089. PubMed ID: 28611053
[TBL] [Abstract][Full Text] [Related]
12. Associations Between Serum 25-Hydroxyvitamin D, Insulin Sensitivity, Insulin Secretion, and β-Cell Function According to Glucose Tolerance Status.
Morisset AS; Tardio V; Weisnagel J; Lemieux S; Bergeron J; Gagnon C
Metab Syndr Relat Disord; 2015 Jun; 13(5):208-13. PubMed ID: 25781493
[TBL] [Abstract][Full Text] [Related]
13. Increased recovery rates of phosphocreatine and inorganic phosphate after isometric contraction in oxidative muscle fibers and elevated hepatic insulin resistance in homozygous carriers of the A-allele of FTO rs9939609.
Grunnet LG; Brøns C; Jacobsen S; Nilsson E; Astrup A; Hansen T; Pedersen O; Poulsen P; Quistorff B; Vaag A
J Clin Endocrinol Metab; 2009 Feb; 94(2):596-602. PubMed ID: 18984658
[TBL] [Abstract][Full Text] [Related]
14. Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals: a cross-sectional study.
Fiorentino TV; Succurro E; Arturi F; Giancotti A; Peronace C; Quirino A; Sesti F; Andreozzi F; Hribal ML; Perticone F; Focà A; Sesti G
Sci Rep; 2018 Sep; 8(1):13616. PubMed ID: 30206293
[TBL] [Abstract][Full Text] [Related]
15. Fat mass largely contributes to insulin mediated glucose uptake in morbidly obese subjects.
Gniuli D; Castagneto-Gissey G; Iaconelli A; Leccesi L; Mingrone G
Int J Obes (Lond); 2010 Dec; 34(12):1726-32. PubMed ID: 20498658
[TBL] [Abstract][Full Text] [Related]
16. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
Daniele G; Guardado Mendoza R; Winnier D; Fiorentino TV; Pengou Z; Cornell J; Andreozzi F; Jenkinson C; Cersosimo E; Federici M; Tripathy D; Folli F
Acta Diabetol; 2014 Feb; 51(1):123-31. PubMed ID: 24370923
[TBL] [Abstract][Full Text] [Related]
17. The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children.
Sentinelli F; Bertoccini L; Barchetta I; Capoccia D; Incani M; Pani MG; Loche S; Angelico F; Arca M; Morini S; Manconi E; Lenzi A; Cossu E; Leonetti F; Baroni MG; Cavallo MG
Nutr Metab Cardiovasc Dis; 2016 May; 26(5):407-13. PubMed ID: 27052925
[TBL] [Abstract][Full Text] [Related]
18. Familial longevity is marked by enhanced insulin sensitivity.
Wijsman CA; Rozing MP; Streefland TC; le Cessie S; Mooijaart SP; Slagboom PE; Westendorp RG; Pijl H; van Heemst D;
Aging Cell; 2011 Feb; 10(1):114-21. PubMed ID: 21070591
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in NR1H4 encoding the bile acid receptor FXR determines fasting glucose and free fatty acid levels in humans.
Heni M; Wagner R; Ketterer C; Böhm A; Linder K; Machicao F; Machann J; Schick F; Hennige AM; Stefan N; Häring HU; Fritsche A; Staiger H
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1224-9. PubMed ID: 23640969
[TBL] [Abstract][Full Text] [Related]
20. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome.
Lewy VD; Danadian K; Witchel SF; Arslanian S
J Pediatr; 2001 Jan; 138(1):38-44. PubMed ID: 11148510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
